|
Re: FDA Breakthrough Therapy Designation -- A "Fast Track" program? Day 120
|
1
|
Resverlogix Corp.
|
May 11, 2020 11:28AM
|
|
Re: Address your Shareholders Donald J. McCaffrey
|
3
|
Resverlogix Corp.
|
May 13, 2020 03:49PM
|
|
Re: Address your Shareholders Donald J. McCaffrey
|
4
|
Resverlogix Corp.
|
May 14, 2020 10:26AM
|
|
Re: Nature Article on the role of Endothelial Cells in COVID 19
|
2
|
Resverlogix Corp.
|
May 24, 2020 09:17AM
|
|
Re: Nature Article on the role of Endothelial Cells in COVID 19
|
2
|
Resverlogix Corp.
|
May 25, 2020 08:27AM
|
|
Re: Canaccord (#33) dumping stock
|
1
|
Resverlogix Corp.
|
May 26, 2020 01:13PM
|
|
Re: Finance
|
1
|
Resverlogix Corp.
|
May 26, 2020 06:00PM
|
|
Re: Finance
|
1
|
Resverlogix Corp.
|
May 26, 2020 06:30PM
|
|
Re: Finance
|
1
|
Resverlogix Corp.
|
May 27, 2020 06:23AM
|
|
Re: Finance
|
|
Resverlogix Corp.
|
May 27, 2020 09:45AM
|
|
Re: Finance
|
2
|
Resverlogix Corp.
|
May 28, 2020 10:42AM
|
|
Re: Breakthrough Designation
|
|
Resverlogix Corp.
|
May 28, 2020 12:52PM
|
|
Re: Breakthrough Designation
|
|
Resverlogix Corp.
|
May 28, 2020 01:52PM
|
|
Re: Breakthrough Designation
|
|
Resverlogix Corp.
|
May 28, 2020 02:29PM
|
|
Re: Breakthrough Designation
|
1
|
Resverlogix Corp.
|
May 28, 2020 03:07PM
|
|
supply vs demand
|
1
|
Resverlogix Corp.
|
May 28, 2020 03:52PM
|
|
Re: Breakthrough Designation
|
|
Resverlogix Corp.
|
May 28, 2020 04:03PM
|
|
Re: Tweet from Prof Kausik Ray
|
3
|
Resverlogix Corp.
|
Jun 01, 2020 05:49AM
|
|
Re: News! - COVID 19 pre-clinical and clinical research trials
|
5
|
Resverlogix Corp.
|
Jun 01, 2020 09:10AM
|
|
Re: Tweet from Prof Kausik Ray
|
4
|
Resverlogix Corp.
|
Jun 01, 2020 10:26AM
|
